AAAAAA

   
Results: 1-16 |
Results: 16
UNSTABLE ANGINA IN THE US - PATIENTS AND MANAGEMENT
Authors: BERDAN LG KLEIMAN NS GUERCI A HOCHMAN JS DAVIDSONRAY L ZILLMAN L HANNAN KL GRETLER D ALLMAN P FULKS JL HARRINGTON RA KITT MM
Citation: Lg. Berdan et al., UNSTABLE ANGINA IN THE US - PATIENTS AND MANAGEMENT, Circulation, 98(17), 1998, pp. 1888-1888
ECONOMIC-ASSESSMENT OF LOW-MOLECULAR-WEIGHT HEPARIN (ENOXAPARIN) VERSUS UNFRACTIONATED HEPARIN IN ACUTE CORONARY SYNDROME PATIENTS - RESULTS FROM THE ESSENCE RANDOMIZED TRIAL
Authors: MARK DB COWPER PA BERKOWITZ SD DAVIDSONRAY L DELONG ER TURPIE AGG CALIFF RM WEATHERLEY B COHEN M
Citation: Db. Mark et al., ECONOMIC-ASSESSMENT OF LOW-MOLECULAR-WEIGHT HEPARIN (ENOXAPARIN) VERSUS UNFRACTIONATED HEPARIN IN ACUTE CORONARY SYNDROME PATIENTS - RESULTS FROM THE ESSENCE RANDOMIZED TRIAL, Circulation, 97(17), 1998, pp. 1702-1707
ECONOMIC-ASSESSMENT OF PLATELET GLYCOPROTEIN IIB IIA RECEPTOR BLOCKADE DURING CORONARY INTERVENTION IN THE EPILOG TRIAL/
Authors: LINCOFF AM MARK DB CALIFF RM TCHENG JE ELLIS SG DAVIDSONRAY L ANDERSON KM STONER GL TOPOL EJ
Citation: Am. Lincoff et al., ECONOMIC-ASSESSMENT OF PLATELET GLYCOPROTEIN IIB IIA RECEPTOR BLOCKADE DURING CORONARY INTERVENTION IN THE EPILOG TRIAL/, Journal of the American College of Cardiology, 29(2), 1997, pp. 97484-97484
RANDOMIZED PLACEBO-CONTROLLED TRIAL OF EFFECT OF EPTIFIBATIDE ON COMPLICATIONS OF PERCUTANEOUS CORONARY INTERVENTION - IMPACT-II
Authors: TCHENG JE LINCOFF AM SIGMON KN LEE KL KITT MM CALIFF RM TOPOL EJ JURAN N WORLEY S TUZI J HOLLYWOOD L KLEIMAN NS ALI MN ROSE D KEREIAKES DJ HIGBY N GEORGE J HEILBRUNN S RONCEVICH T BURNHEIMER B IVANHOE R MEADE L RUND M TANNENAUM M STANGLE D YAKUBOV S RUSK K FERGUSON JJ WILLERSON JT THOMAS C HARLAN M BROWNE K TELATNIK M BLANKENSHIP J DEMKO L TIMMIS G SAFIAN M RESAR J DUDEK A SPRIGGS D WAHL S GILCHRIST IC DABBS A SHADOFF N GOEBEL S MILLER M BURDICK M OWENS B MCIVOR M REDDINGER J HARTMAN C LUNOW S CONN E MCWILLIAMS C AYCOCK R WILCOX T CORBELLI J COOKE B TEIRSTEIN P HAAS G TALLEY JD RAWERT M GHALILI K MAHAFFEY T TOGGART E FOWLER P DAVIDSON C BERGELSON B SCHAECHTER A NAVETTA F BYARS S DURBIN B MUHLESTEIN JB JERMAN J NYGAARD T WHITE J SANZ M MAYER D WHITE R REATTA K AGUIRRE FV STONNER T GOTTLIEB R LAVOIE J MCDONOUGH T WESZT S MICALE P BERRY S TAYLOR M CLARK D BREWER D BLACK S ROUBIN G SUTOR C HEINSIMER J ALLAR N CRAWFORD R PIERSON M SIEGEL R VERMILLION J BENGTSON J PROCHNOW L GRIFFIN J THEODOSIOU J PARR K THOMAS L TOOLE J WISE C LERRICK K SPINAGOTTI B FRENCH W NAGELHOUT D MILLER K SEAWORTH J JENSON J COLLINS G MARK R SHEIKH K ROSNER E TENAGLIA A FRIEDMAN I WEINER B BORBONE M KUEHL W ALLEN S KRAUTHAMER D CHAIT V BELKIN R STEINBERG R CAREY D ROGERS K CATES C DAVIS D ARNOLD A SOMMERS T HERZOG W CALAMUNCI N COWFER J COHEN M LEE D SLOSKY D KACZINSKI J SIMONTON C PORTER B HINOHARA T JOHNSON M DELCORE M STANGAL L GACIOCH G CHIODO V SULLEBARGER JT FORD L KLEAVEL P FEDAK C POPMA J PRUNKA N DAVIS C FAXON D GUERCI A LOSCALZO J WEAVER WD BATTS K HUGHES D JOSEPH D KARNASH S LILLEY P LIU M MELTON J MESSICK M OWENS E PASSMORE D PULLIUM M SHAVENDER J SMITH D SMITH M SNAPP J STOSIK V SUMNER D THEL MC THOMPSON G WORKMAN J BY S CARTER J GORDON C GOTHARD P GRANGER CB HARRINGTON RA KRUSE KR MAHAFFEY KW MCCLANAHAN M MILLER M OHMAN EM PITZER L TARDIFF B WINCHELL M CROWE T DEBOWEY D GATES K STARR S WAGNER GS DAVIDSONRAY L MARK DB DUMEE C KITT M LORENZ T OBRIEN M SCARBOROUGH R SWIFT R
Citation: Je. Tcheng et al., RANDOMIZED PLACEBO-CONTROLLED TRIAL OF EFFECT OF EPTIFIBATIDE ON COMPLICATIONS OF PERCUTANEOUS CORONARY INTERVENTION - IMPACT-II, Lancet, 349(9063), 1997, pp. 1422-1428
PLATELET GLYCOPROTEIN IIB IIIA RECEPTOR BLOCKADE AND LOW-DOSE HEPARINDURING PERCUTANEOUS CORONARY REVASCULARIZATION/
Authors: TOPOL EJ CALIFF RM LINCOFF AM TCHENG JE CABOT CF WEISMAN HF KEREIAKES D LAUSTEN D RUNYON JP HOWARD W KELLY T MUNCY D TIMMIS G SAFIAN M DAVEY D KLEIMAN NS ROSE D BASINGER L ROUSE C KRAMER J WILSON R TALLEY JD BOYLES M NAVETTA FI LEBUEUF R KRAFT P DVORAK L SMIGLA RM FERGUSON J HARLAN M BROWNE K TELATNIK M BLANKENSHIP J DEMKO L IVANHOE RJ JACKSON C SHADOFF N GOEBEL S TAYLOR M CLEARY E GACIOCH G CHIODO V BATES E QUAIN L SNYDER H BASS TA ROHMAN C GRADMAN A BOLTEY L TANNENBAUM M STENGL D GORDON P WRIGHT N CUMMINS F NONNWEILER J AVERSANO T PELTZER L BEAR P CRAIG MB HATTEL L TOOKE G ANDERSON HV WEIGELT L HETTLEMAN B KENNEDY S TEIRSTEIN PS CLAIRE D SAREMBOCK I SAYRE S DAVIDSON CJ SCHAECHTER A AGUIRRE F STONNER T AZRIN M BODETT J BARRY MB WORLEY S FREY LA SPRIGGS DJ WAHL SA WESTON MW YEDINAK K GEORGE B SMITH D GILLILAND C SMITH D RICCI DR FOX R HARTMAN C LUNOW S FARAH T PETRUOLO S SANDER G STEVENS A DELISE K REEN B WHISNANT D HENDERSON L HEUSER R SWIDERSKI K KALUZNIAK M LARKIN T JACKSON BJ POPMA J PRUNKA N SANZ M MAYER D MACKEY K BURTON J HOGG N BROWN R STEVENS K FRENCH W WANG S ADELMAN AG FOULGER V WEBER S GOTTLIEB R LAVOIE J KING S FRERICHS F HOLLYWOOD L DUCAS J SCHICK U HOCHMAN JS SLATER J TORMEY D ONEILL BJ FOSHAY K FITZGERALD N CHEUNG PK BEDARD D KNUDTSON ML GALBRAITH D WATT H SAMAHA J HAMILTON B KLEIN LW HEBSON L ALMOND D WHITE J ROSENBERG MJ TEULLY S UNKS M RODGERS K FAXON D GORE J KELSEY S LEE K SANE D WALTERS L BOOTH J CANNATA R CASTLE V COHEN H DELUCA S KUTNER M KNUTH T MCCOLLOUGH T MCPHERSON J MELTON J MILLER D PULLIAM M SAPP S SIGMON KN MONTAGUE E ALEXANDER K AUGOSTINI R BAJZER C BART B BELLI G CARLSON J CHALLAPALLI R CRENSHAW B DAWSON I DICKEY A ECHOLS A ERICKSON B FONTANA MB GHAFFARI S GORDON C GRANGER C GRANO G GRIMM R JOHNSON T JURAN N KINGSLEY A KRUSE K LAUER M MAHAFFEY K MALONE K MARK D MARWICK T MIGRINO R MILLER J NEWBY K PACE C PETERSON E RABBANI R RAGAN J RIMMERMAN C RODKEY S SAVOR V SHAW WF SILA C SILVER M TAN W TOBIASZ D VANDERVOORT P WANG CW WARD C WATERS J WIEHLE D WINCHELL M UNDERWOOD D CLEMONS P HEUPLER S POWERS J RUBIN D SGARBOSSA E STEINHUBL S MOLITERNO D DEBOWEY D BALAZS E CROWE T IVANC T OLS L POLISZCZUK R VILSACK H WITHERSPOON B DAVIDSONRAY L ANDERSON KM GIEL KM MUSCO MH STONER GL
Citation: Ej. Topol et al., PLATELET GLYCOPROTEIN IIB IIIA RECEPTOR BLOCKADE AND LOW-DOSE HEPARINDURING PERCUTANEOUS CORONARY REVASCULARIZATION/, The New England journal of medicine, 336(24), 1997, pp. 1689-1696
EFFECTS OF STROKE ON MEDICAL RESOURCE CONSUMPTION AND COSTS IN SURVIVORS OF ACUTE MYOCARDIAL-INFARCTION
Authors: TUNG CY SLOAN MB KNIGHT JD WEAVER WD MAHAFFEY KW WHITE HD GORE JM DAVIDSONRAY L MARK DB
Citation: Cy. Tung et al., EFFECTS OF STROKE ON MEDICAL RESOURCE CONSUMPTION AND COSTS IN SURVIVORS OF ACUTE MYOCARDIAL-INFARCTION, Circulation, 96(8), 1997, pp. 3152-3152
ECONOMIC-IMPLICATIONS OF THE PROPHYLACTIC USE OF INTRAAORTIC BALLOON COUNTERPULSATION IN THE SETTING OF ACUTE MYOCARDIAL-INFARCTION
Authors: TALLEY JD OHMAN EM MARK DB GEORGE BS LEIMBERGER JD BERDAN LG DAVIDSONRAY L RAWERT M LAM LC PHILLIPS HR CALIFF RM
Citation: Jd. Talley et al., ECONOMIC-IMPLICATIONS OF THE PROPHYLACTIC USE OF INTRAAORTIC BALLOON COUNTERPULSATION IN THE SETTING OF ACUTE MYOCARDIAL-INFARCTION, The American journal of cardiology, 79(5), 1997, pp. 590-594
COSTS OF DIRECT ANGIOPLASTY VERSUS THROMBOLYSIS FOR ACUTE MYOCARDIAL-INFARCTION - RESULTS FROM THE GUSTO-II RANDOMIZED TRIAL
Authors: MARK DB GRANGER CB ELLIS SG PHILLIPS HR KNIGHT D DAVIDSONRAY L TOPOL EJ
Citation: Db. Mark et al., COSTS OF DIRECT ANGIOPLASTY VERSUS THROMBOLYSIS FOR ACUTE MYOCARDIAL-INFARCTION - RESULTS FROM THE GUSTO-II RANDOMIZED TRIAL, Circulation, 94(8), 1996, pp. 973-973
DOES A SUCCESSFUL CORONARY INTERVENTIONAL PROCEDURE PREDICT IMPROVEMENT IN A PATIENTS QUALITY-OF-LIFE
Authors: DELUCA SA DAVIDSONRAY L LAM TC PRONESTI LR MARK DB
Citation: Sa. Deluca et al., DOES A SUCCESSFUL CORONARY INTERVENTIONAL PROCEDURE PREDICT IMPROVEMENT IN A PATIENTS QUALITY-OF-LIFE, Circulation, 94(8), 1996, pp. 4199-4199
ECONOMIC-ASSESSMENT OF PLATELET GLYCOPROTEIN IIB IIIA INHIBITION FOR PREVENTION OF ISCHEMIC COMPLICATIONS OF HIGH-RISK CORONARY ANGIOPLASTY/
Authors: MARK DB TALLEY JD TOPOL EJ BOWMAN L LAM LC ANDERSON KM JOLLIS JG CLEMAN MW LEE KL AVERSANO T UNTEREKER WJ DAVIDSONRAY L CALIFF RM
Citation: Db. Mark et al., ECONOMIC-ASSESSMENT OF PLATELET GLYCOPROTEIN IIB IIIA INHIBITION FOR PREVENTION OF ISCHEMIC COMPLICATIONS OF HIGH-RISK CORONARY ANGIOPLASTY/, Circulation, 94(4), 1996, pp. 629-635
BASE-LINE AND 6-MONTH COSTS OF PRIMARY ANGIOPLASTY THERAPY FOR ACUTE MYOCARDIAL-INFARCTION - RESULTS FROM THE PRIMARY ANGIOPLASTY REGISTRY
Authors: MARK DB ONEILL WW BRODIE B IVANHOE R KNOPF W TAYLOR G OKEEFE JH GRINES CL DAVIDSONRAY L KNIGHT JD CALIFF RM
Citation: Db. Mark et al., BASE-LINE AND 6-MONTH COSTS OF PRIMARY ANGIOPLASTY THERAPY FOR ACUTE MYOCARDIAL-INFARCTION - RESULTS FROM THE PRIMARY ANGIOPLASTY REGISTRY, Journal of the American College of Cardiology, 26(3), 1995, pp. 688-695
ECONOMIC OUTCOMES FOLLOWING CORONARY ANGIOPLASTY VERSUS CORONARY ATHERECTOMY - RESULTS FROM THE CAVEAT RANDOMIZED TRIAL
Authors: MARK DB TALLEY JD LAM LC BERDAN LG DAVIDSONRAY L CALIFF RM TOPOL EJ
Citation: Db. Mark et al., ECONOMIC OUTCOMES FOLLOWING CORONARY ANGIOPLASTY VERSUS CORONARY ATHERECTOMY - RESULTS FROM THE CAVEAT RANDOMIZED TRIAL, Journal of the American College of Cardiology, 1994, pp. 10000284-10000284
ECONOMIC-IMPACT OF ABRUPT CLOSURE FOLLOWING PERCUTANEOUS INTERVENTION- THE CAVEAT EXPERIENCE
Authors: BERDAN LG HOLMES DR DAVIDSONRAY L LAM LC TALLEY JD MARK DB
Citation: Lg. Berdan et al., ECONOMIC-IMPACT OF ABRUPT CLOSURE FOLLOWING PERCUTANEOUS INTERVENTION- THE CAVEAT EXPERIENCE, Journal of the American College of Cardiology, 1994, pp. 10000434-10000434
USE OF A MONOCLONAL-ANTIBODY DIRECTED AGAINST THE PLATELET GLYCOPROTEIN IIB IIIA RECEPTOR IN HIGH-RISK CORONARY ANGIOPLASTY/
Authors: CALIFF RM SHADOFF N VALETT N BATES E GALEANA A KNOPF W SHAFTEL J BENDER MJ AVERSANO T RAQUENO J GURBEL P COWFER J COHEN M CROSS P BITTL J EDDINGS K TAYLOR M DEROSA K HATTEL L COOPER L ESHELMAN B FINTEL D NIEMYSKI P KLEIN L KENNEDY H THORNTON T KEREIAKES D MARTIN L ANDERSON L HIGBY N ELLIS S BREZINA K GEORGE B CHAPEKIS A SMITH D ANWAR A GERBER TL PRITCHARD GL MYLER R SHAW R MURPHY M WARD K MADIGAN NP BLANKENSHIP J HALBERT M FLANAGAN C TANNENBAUM M POLICH M STEVENSON C TCHENG J HOFFMAN S MOORE RM SMITH J HENRY P MCDONOUGH TJ WESZT S BRODIE B MUNCY D KLEIMAN N TRAINOR K ROSE D JOHNSON S WILLERSON J FERGUSON JJ HARLAN M BASS TA ROHMAN G BROWNE K CIESLA C WORLEY S TUZI J HETTLEMAN B BURKE WC OLSEN G KENNEDY SJ TALLEY JD YUSSMAN ZA RAWERT M GRASSMAN ED WRONA L SAMAHA J EHEMANN B BLEICH SD LEONHARD R CUMMINS F NONNWEILER J SANZ M MAYER D CLEMAN MW PASCALE VJ MCCONNELL S DELCORE M STENGEL L IVANHOE RJ GRANGER N ROSENBERG MJ SCHAECHTER A AYCOCK G WILCOX T GOTTLIEB R HUNTER H UNTERECKER W HART B HEUSER R HOOPMANN S HANOVICH G ANTOLICK A GACIOCH G CHIODO V KARSKI K TIMMIS G SAFIAN M AGUIRRE F STONNER T TAYLOR GJ WOMACK K RUYLE B KRAUTHAMER D WELCOM G WESTON M DILLON K FRENCH WJ REYNOLDS GT NAVETTA F MURPHY G LEBOEUF R SPENCER S POPMA JJ SWEET L TOPOL EJ SMITH CR WEISMAN H LEE KL MILLER J SIGMON K TCHENG J LEE KL LUI M KOSLOFF A DIFULVIO J WANG AL ANDERSON K WEISMAN H DANN R KINGMA W NORTON D MYER B MASEK R LEWANDOWSKI M BRODERICK S MUSCO M SCHORR M HARTMAN P MCCARDLE L FAXON D ARMSTRONG P GORE J LOSCALZO J MCCULLOUGH L VERTER J MARK DB DAVIDSONRAY L CLAPPCHANNING N LAM LC WAUGH RA MCCANTS CB HINDMAN MC DEHMER G HILLEGASS WB FRID DJ FORTIN DF BROTT BC FOREST TL UNKS DM HAMER ME WAGNER GS GATES K SANE D
Citation: Rm. Califf et al., USE OF A MONOCLONAL-ANTIBODY DIRECTED AGAINST THE PLATELET GLYCOPROTEIN IIB IIIA RECEPTOR IN HIGH-RISK CORONARY ANGIOPLASTY/, The New England journal of medicine, 330(14), 1994, pp. 956-961
REDUCED RESTENOSIS FROM AGGRESSIVE PLATELET INHIBITION REDUCES COSTS OF HIGH-RISK ANGIOPLASTY - RESULTS FROM THE EPIC RANDOMIZED TRIAL
Authors: MARK DB TALLEY JD LAM LC DAVIDSONRAY L BOWMAN L
Citation: Db. Mark et al., REDUCED RESTENOSIS FROM AGGRESSIVE PLATELET INHIBITION REDUCES COSTS OF HIGH-RISK ANGIOPLASTY - RESULTS FROM THE EPIC RANDOMIZED TRIAL, Circulation, 90(4), 1994, pp. 44-44
REDUCED RESTENOSIS FROM AGGRESSIVE PLATELET INHIBITION REDUCES COSTS OF HIGH-RISK ANGIOPLASTY - RESULTS FROM THE EPIC RANDOMIZED TRIAL
Authors: MARK DB TALLEY JD LAM LC DAVIDSONRAY L BOWMAN L
Citation: Db. Mark et al., REDUCED RESTENOSIS FROM AGGRESSIVE PLATELET INHIBITION REDUCES COSTS OF HIGH-RISK ANGIOPLASTY - RESULTS FROM THE EPIC RANDOMIZED TRIAL, Circulation, 90(4), 1994, pp. 44-44
Risultati: 1-16 |